Minocycline may be useful to prevent/treat postoperative cognitive decline in elderly patients

Medical Hypotheses

Volumn 76, Issue 5, 2011, Pages 733-736

  Fan, L ^a   Wang, Tian Long ^a   Xu, Y C ^a   Ma, Y H ^a   Ye, W G ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MINOCYCLINE;

ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; COGNITIVE DEFECT; DISEASE COURSE; DRUG EFFICACY; DRUG MECHANISM; HEART SURGERY; HUMAN; HUNTINGTON DISEASE LIKE SYNDROME; INFLAMMATION; NONHUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; RISK FACTOR;

AGED; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; BRAIN DISEASES; COGNITION DISORDERS; HUMANS; INFLAMMATION; MINOCYCLINE; MODELS, THEORETICAL; NEURODEGENERATIVE DISEASES; POSTOPERATIVE COMPLICATIONS; SEPSIS; TETRACYCLINE; TREATMENT OUTCOME;

EID: 79954423221     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.02.010     Document Type: Article

References (38)

1. Rubens F.D., Boodhwani M., Nathan H. Interpreting studies of cognitive function following cardiac surgery: a guide for surgical teams. Perfusion 2007, 22(3):185-192.
2. Lu Y., Wu X., Dong Y., Xu Z., Zhang Y., Xie Z. Anesthetic sevoflurane causes neurotoxicity differently in neonatal naïve and Alzheimer disease transgenic mice. Anesthesiology 2010, 112(6):1404-1416.
3. Xiong J., Xue F.S., Liu J.H., et al. Transcutaneous vagus nerve stimulation may attenuate postoperative cognitive dysfunction in elderly patients. Med Hypotheses 2009, 73(6):938-941.
4. Wan Y., Xu J., Ma D., Zeng Y., Cibelli M., Maze M. Postoperative impairment of cognitive function in rats: a possible role for cytokine-mediated inflammation in the hippocampus. Anesthesiology 2007, 106(3):436-443.
5. Wan Y, Xu J, Meng F, et al. Cognitive decline following major surgery is associated with gliosis, beta-amyloid accumulation, and tau phosphorylation in old mice. Crit Care Med 2010 [Epub ahead of print].
6. Hu Z., Ou Y., Duan K., Jiang X. Inflammation: a bridge between postoperative cognitive dysfunction and Alzheimer's disease. Med Hypotheses 2010, 74(4):722-724.
7. Stroobant N., Van Nooten G., Belleghem Y., Vingerhoets G. Short-term and long-term neurocognitive outcome in on-pump versus off-pump CABG. Eur J Cardiothorac Surg 2002, 22:559-564.
8. Gao Lan, Taha Rame, Gauvin Dominique, et al. Postoperative cognitive dysfunction after cardiac surgery. Chest 2005, 3664-3670.
9. Choi Y., Kim H.S., Shin K.Y., et al. Minocycline attenuates neuronal cell death and improves cognitive impairment in Alzheimer's disease models. Neuropsychopharmacology 2007, 32(11):2393-2404.
10. Palazuelos J., Aguado T., Pazos M.R., et al. Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity. Brain 2009, 132(Pt. 11):3152-3164.
11. Murray C, Sanderson DJ, Barkus C, et al. Systemic inflammation for delirium. Neurobiol Aging 2010;12 [Epub ahead of print].
12. Cerejeira J., Firmino H., Vaz-Serra A., et al. The neuroinflammatory hypothesis of delirium. Acta Neuropathol 2010, 119(6):737-754.
13. Tan Z.S., Beiser A.S., Vasan R.S., et al. Inflammatory markers and the risk of Alzheimer disease: the Framingham Study. Neurology 2007, 68(22):1902-1908.
14. Holmes C., Cunningham C., Zotova E., et al. Systemic inflammation and disease progression in Alzheimer disease. Neurology 2009, 73(10):768-774.
15. Finch C.E., Morgan T.E., et al. Systemic inflammation, infection, ApoE alleles, and Alzheimer disease: a position paper. Curr Alzheimer Res 2007, 4(2):185-189.
16. Weberpals M., Hermes M., Hermann S., et al. NOS2 gene deficiency protects from sepsis-induced long-term cognitive deficits. J Neurosci 2009, 29(45):14177-14184.
17. Lemstra A.W., Groen J.C., Hoozemans J.J., et al. Microglia activation in sepsis: a case-control study. J Neuroinflammat 2007, 15(4):4.
18. Kálmán J., Juhász A., Bogáts G., et al. Elevated levels of inflammatory biomarkers in the cerebrospinal fluid after coronary artery bypass surgery are predictors of cognitive decline. Neurochem Int 2006, 48(3):177-180.
19. Henry C.J., Huang Y., Wynne A., et al. Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia. J Neuroinflammat 2008, 13(5):15.
20. Seabrook Timothy J., Jiang Liying, et al. Minocycline affects microglia activation, Ab deposition, and behavior in APP-tg mice. Glia 2006, 53:776-782.
21. Leonardo C.C., Hall A.A., Collier L.A., et al. Inhibition of gelatinase activity reduces neural injury in an ex vivo model of hypoxia-ischemia. Neuroscience 2009, 160(4):755-766.
22. Liu Z., Fan Y., Won S.J., et al. Chronic treatment with minocycline preserves adult new neurons and reduces functional impairment after focal cerebral ischemia. Stroke 2007, 38(1):146-152.
23. Weng Yuan Cheng, Kriz Jasna Differential neuroprotective effects of a minocycline-based drug cocktail in transient and permanent focal cerebral ischemia. Exp Neurol 2007, 204(1):433-442.
24. Homi H.M., Calvi C.L., Lynch J., et al. Longitudinal assessment of neurocognitive function in rats after cardiopulmonary bypass: evidence for long-term deficits. J Cardiothorac Vasc Anesth 2010, 24(2):293-299.
25. Ma D., Yang H., Lynch J., et al. Xenon attenuates cardiopulmonary bypass-induced neurologic and neurocognitive dysfunction in the rat. Anesthesiology 2003, 98(3):690-698.
26. Mackensen G.B., Sato Y., Nellgard B., et al. Cardiopulmonary bypass induces neurologic and neurocognitive dysfunction in the rat. Anesthesiology 2001, 95(6):1485-1491.
27. Grocott H.P., Homi H.M., Puskas F. Cognitive dysfunction after cardiac surgery: revisiting etiology. Semin Cardiothorac Vasc Anesth 2005, 9(2):123-129.
28. de Lange F., Jones W.L., Mackensen G.B., Grocott H.P. The effect of limited rewarming and postoperative hypothermia on cognitive function in a rat cardiopulmonary bypass model. Anesth Analg 2008, 1069(3):739-745.
29. Grigore A.M., Murray C.F., Ramakrishna H., Djaiani G. A core review of temperature regimens and neuroprotection during cardiopulmonary bypass: does rewarming rate matter?. Anesth Analg 2009, 109(6):1741-1751.
30. Xie Z., Dong Y., Maeda U., et al. Isoflurane-induced apoptosis: a potential pathogenic link between delirium and dementia. J Gerontol A: Biol Sci Med Sci 2006, 61(12):1300-1306.
31. Fan R., Xu F., Previti M.L., et al. Minocycline reduces microglial activation and improves behavioral deficits in a transgenic model of cerebral microvascular amyloid. J Neurosci 2007, 27(12):3057-3063.
32. Cai Z.Y., Yan Y., Chen R. Minocycline reduces astrocytic reactivation and neuroinflammation in the hippocampus of a vascular cognitive impairment rat model. Neurosci Bull 2010, 26(1):28-36.
33. Raghavendra V., Tanga F., Deleo J.A. Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J Pharmacol Exp 2003, 306:624-630.
34. Zanjani T.M., Sabetkasaei M., Mosaffa N., Manaheji H., Labibi F., Farokhi B. Suppression of interleukin-6 by minocycline in a rat model of neuropathic pain. Eur J Pharmacol 2006, 538:66-72.
35. Mizoguchi H., Takuma K., Fukakusa A., et al. Improvement by minocycline of methamphetamine-induced impairment of recognition memory in mice. Psychopharmacology 2008, 196(2):233-241.
36. Legault C., Furberg C.D., Wagenknecht L.E., et al. Nimodipine neuroprotection in cardiac valve replacement: report of an early terminated trial. Stroke 1996, 27(4):593-598.
37. Mitchell Simon J., Merry Alan F., Frampton Christopher, et al. Cerebral protection by lidocaine during cardiac operations: a follow-up study. Ann Thorac Surg 2009, 879(3):820-825.
38. Boodhwani M., Rubens F.D., Wozny D., et al. Predictors of early neurocognitive deficits in low-risk patients undergoing on-pump coronary artery bypass surgery. Circulation 2006, 114(1):I461-I466.